脂蛋白 (a) 水平和心力衰竭的不良结果
Adithya K Yadalam1, Apoorva Gangavelli2, Alexander C Razavi1
1Department of Medicine, Division of Cardiology, Emory University School of Medicine, Atlanta, Georgia.
Journal of cardiac failure
|April 6, 2025
概括
升高的脂蛋白[Lp]水平 (≥30 mg/dL) 独立预测慢性心力衰竭 (HF) 患者的心血管死亡或心力衰竭住院治疗. 这一发现突出了Lp (a) 作为HF群体中显著的风险标志物.
科学领域:
- 心脏病学 心脏病学
- 遗传学 遗传学是一种遗传学.
- 生物标志物 生物标志物
背景情况:
- 脂蛋白 (Lp) 的升高与新发性心力衰竭 (HF) 有关.
- 对于已确定的慢性HF中心血管事件的升高Lp(a) 的预测值仍然不清楚.
研究的目的:
- 调查慢性HF患者的Lp(a) 水平和不良心血管结果之间的关联.
- 为了确定Lp(a) 是否预测心血管死亡和HF患者的HF住院治疗.
主要方法:
- 1088名接受心脏导管治疗的HF患者被分为两层,分为Lp (a) 组 (<30,30-49,≥50 mg/dL).
- 主要结局:心血管死亡和HF住院治疗的组合.
- 竞争风险建模调整以人口统计学,风险因素,射出分数和大脑 natriuretic 的 N-终端前激素为准.
主要成果:
- 与Lp (a) <30 mg/dL相比,较高的Lp (a) 水平 (30-49 mg/dL和≥50 mg/dL) 与心血管死亡或HF住院的风险明显增加有关.
- 多变量调整显示,中等和高Lp (a) 组的分发危险比分别为1.35和1.38.
- 这种关联随着时间的推移呈现下降趋势,在缺血性高血压中名义上更强,尽管在多次测试调整后在统计学上并不显著.
结论:
- 脂蛋白 (a) 含量≥30 mg/dL独立预测HF患者心血管死亡或HF住院的风险.
- 在慢性心力衰竭中,Lp (a) 作为一种有价值的独立风险标志物,用于慢性心力衰竭的不良结果.
相关概念视频
Blood Studies for Cardiovascular System III: Serum Lipid Profile
108
Understanding serum lipids is crucial for maintaining cardiovascular health and preventing heart disease and stroke.
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
108
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
38
Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
38
Pathophysiology of Heart Failure
1.4K
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
1.4K
Lipid-Lowering Drugs: Statins and Miscellaneous Agents
475
Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
475
Cholesterol: Significance and Regulation
462
Although not a source of energy, cholesterol plays a significant role as a foundational structure for bile salts, steroid hormones, and vitamin D, as well as being a crucial component of plasma membranes. Approximately 15% of blood cholesterol is derived from our diet, with the remainder synthesized from acetyl CoA by the liver and intestines. Cholesterol is eliminated from the body through its conversion into bile salts, which are eventually discarded in the feces.
Considering cholesterol and...
Considering cholesterol and...
462
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
331
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
331


